Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis

類似資料

• VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses
  著者:: Tan, Yossan-Var, 等
  出版事項: (2014)
• Pituitary Adenylate Cyclase Activating Peptide Deficient Mice Exhibit Impaired Thymic and Extrathymic Regulatory T Cell Proliferation during EAE
  著者:: Tan, Yossan-Var, 等
  出版事項: (2013)
• Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor
  著者:: Martinez, Carmen, 等
  出版事項: (2002)
• Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures
  著者:: Cohen, Joseph R, 等
  出版事項: (2010)
• Pituitary Adenylyl Cyclase-Activating Polypeptide Stimulates DNA Synthesis But Delays Maturation of Oligodendrocyte Progenitors
  著者:: Lee, Matthew, 等
  出版事項: (2001)